What's the Evidence for Fluvoxamine in COVID-19?

The US FDA ’s decision not to grant an emergency use authorization for the antidepressant as a COVID-19 treatment highlights a lack of consensus among researchers about how to interpret clinical data...
Source: The Scientist - Category: Science Tags: News & Opinion Source Type: news